Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -4.650% | 5.392% | -13.655% | 157.485% | 29.518% | 9.694% | -63.559% |
| Northwest Biotherapeutics Inc. | - | -11.111% | -11.111% | -15.789% | -22.330% | -70.370% | -85.965% |
| Celldex Therapeutics | 3.390% | 14.315% | 7.386% | 92.857% | 28.864% | -4.866% | 62.931% |
News
Nvidia Built an AI Chip Empire. But It's This Other Creation That Makes the Stock a Screaming Buy Today.
Nvidia (NASDAQ: NVDA) is known for its artificial intelligence (AI) chips. These graphics processing units (GPUs) power some of the most critical tasks in the field, from training large language
2 AI Stocks That Survived the March Sell-Off -- and Look Stronger Because of It
The March sell-off hit even the hottest areas of technology. However, not every tech stock was down for the month, and one pair of stocks in particular stood out as not only surviving the sell-off
AMD vs. Nvidia: The AI Supercycle Is Big Enough for Both. Here's the Better Buy.
The artificial intelligence (AI) boom is creating massive winners, but not every stock riding this wave will deliver the same type of returns for investors.
Nvidia (NASDAQ: NVDA) and Advanced Micro